A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes

A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Israel Zelikovic, Raymonde Szargel, Ali Hawash, Valentina Labay, Ihab Hatib, Nadine Cohen, Farid Nakhoul
Format:	Artigo
Jezik:	angleščina
Izdano:	2003
Online dostop:	https://doi.org/10.1046/j.1523-1755.2003.00730.x
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Mutations in the Chloride Channel Gene, CLCNKB, Leading to a Mixed Bartter-Gitelman Phenotype
od: Nikola Jeck, et al.
Izdano: (2000)

Mutations in the Chloride Channel Gene CLCNKB as a Cause of Classic Bartter Syndrome
od: Martin Konrad, et al.
Izdano: (2000)

A novel mutation of CLCNKB in a Korean patient of mixed phenotype of Bartter-Gitelman syndrome
od: Cho, Hee-Won, et al.
Izdano: (2016)

Gitelman or Bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation
od: Cruz, António José, et al.
Izdano: (2013)

Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene
od: Al-Shibli, Amar, et al.
Izdano: (2014)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
od: Bamgbola, Oluwatoyin Fatai, et al.
Izdano: (2021)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
od: Bamgbola, Oluwatoyin Fatai, et al.
Izdano: (2020)

Molecular pathogenesis of Bartter’s and Gitelman’s syndromes
od: Ira Kurtz, et al.
Izdano: (1998)

Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo–Bartter/Gitelman syndrome based on clinical characteristics
od: Natsuki Matsunoshita, et al.
Izdano: (2015)

Bartter and Gitelman syndromes: Questions of class
od: Besouw, Martine T. P., et al.
Izdano: (2019)

Bartter and Gitelman syndromes: Questions of class
od: Martine Besouw, et al.
Izdano: (2019)

Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome
od: Cheng, Chih‐Jen, et al.
Izdano: (2017)

Splicing Characterization of CLCNKB Variants in Four Patients With Type III Bartter Syndrome
od: Wang, Chunli, et al.
Izdano: (2020)

Erratum: Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome
od: Han, Jin Suk
Izdano: (2016)

Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome
od: Palazzo, Viviana, et al.
Izdano: (2022)

The pathophysiological and molecular basis of Bartter's and Gitelman's syndromes
od: Bhandari, S.
Izdano: (1999)

Clinical and diagnostic features of Bartter and Gitelman syndromes
od: Walsh, Patrick R, et al.
Izdano: (2018)

Clinical and diagnostic features of Bartter and Gitelman syndromes
od: Patrick R. Walsh, et al.
Izdano: (2017)

Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes
od: Samuele Corbetta, et al.
Izdano: (2014)

Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations
od: Al Shibli, Amar, et al.
Izdano: (2015)

Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations
od: Amar Al Shibli, et al.
Izdano: (2015)

Mutations in<i>SLC12A3</i>and<i>CLCNKB</i>and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome
od: Jae Wook Lee, et al.
Izdano: (2016)

A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report
od: Zhu, Binlu, et al.
Izdano: (2019)

Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome
od: Kong, Yuanmei, et al.
Izdano: (2019)

A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration
od: Ohkubo, Kumiko, et al.
Izdano: (2014)

Correction to: Digenic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome
od: Kong, Yuanmei, et al.
Izdano: (2019)

The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes
od: Francini, Francesco, et al.
Izdano: (2021)

Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
od: Seyberth, Hannsjörg W., et al.
Izdano: (2011)

Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
od: Hannsjörg W. Seyberth, et al.
Izdano: (2011)

Vascular tone control in humans: Insights from studies in Bartter's/Gitelman's syndromes
od: L.A. Calò
Izdano: (2006)

A Chinese Girl with Bartter Syndrome Type III due to a Novel Mutation and/or Single Nucleotide Polymorphisms (SNPs) in CLCNKB Gene
od: Wang, Xiumin, et al.
Izdano: (2013)

Two novel mutations in the CLCNKB gene leading to classic Bartter syndrome presenting as syncope and hypertension in a 13-year-old boy
od: Le, Binh T, et al.
Izdano: (2020)

Evaluation of support events for individuals with Gitelman/Bartter syndromes and their families: participant feedback and reflections
od: Boluda, Susana B, et al.
Izdano: (2019)

ACE2 and prognosis of COVID‐19: Insights from Bartter's and Gitelman's syndromes patients
od: Calò, Lorenzo A., et al.
Izdano: (2020)

Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians
od: Nuñez-Gonzalez, Laura, et al.
Izdano: (2021)

Diuretic loading test and use of Bartter's Normogram in diagnosing a case of Gitelman's syndrome: Relook into pathophysiology
od: Goswami, R. P., et al.
Izdano: (2011)

Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome
od: Tang, Wangna, et al.
Izdano: (2022)

The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing
od: Stevenson, Mark, et al.
Izdano: (2022)

Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the CLCNKB gene linked to Bartter syndrome type III in Spain
od: Peces, Ramón, et al.
Izdano: (2021)

Far di Necessità Virtù, using rare tubulopathies, Gitelman’s and Bartter’s syndromes, to inform the fight against COVID-19
od: Calò, Lorenzo A., et al.
Izdano: (2021)